David S. Y. Ong

6.6k citations

87 papers · 3.0k indexed · h-index 27

Epidemiology top 2%
Critical Care and Intensive Care Medicine top 0.2%
Infectious Diseases top 2%
Pulmonary and Respiratory Medicine top 5%
Immunology top 10%

Co-authors: Olaf L. Cremer Peter M. C. Klein Klouwenberg Marc J. M. Bonten Marcus J. Schultz Tom van der Poll Lonneke A. van Vught Janneke Horn Jos F. Frencken
Topics: Sepsis Diagnosis and Treatment (18 papers)SARS-CoV-2 and COVID-19 Research (15 papers)COVID-19 Clinical Research Studies (13 papers)
Cited by: Critical Care and Intensive Care Medicine Applied Microbiology and Biotechnology Epidemiology
Journals: SHILAP Revista de lepidopterologíaBlood American Journal of Respiratory and Critical Care Medicine
Partner nations: Netherlands United States United Kingdom

In The Last Decade

David S. Y. Ong

85 papers receiving 2.9k citations

Peers

Countries citing papers authored by David S. Y. Ong

Since Specialization

Citations

This map shows the geographic impact of David S. Y. Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Y. Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Y. Ong more than expected).

Fields of papers citing papers by David S. Y. Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Y. Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Y. Ong. The network helps show where David S. Y. Ong may publish in the future.

Co-authorship network of co-authors of David S. Y. Ong

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Y. Ong. A scholar is included among the top collaborators of David S. Y. Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Y. Ong. David S. Y. Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cytomegalovirus reactivation and the host immune response in patients with sepsis 2025 ·Journal of Infection ·Justin de Brabander,David S. Y. Ong,Olaf L. Cremer,Lieuwe D. J. Bos,(unknown),Diederik van de Beek	0
2	Consensus recommendations on the use of injectable poly‐l‐lactic acid in Asian patients 2023 ·Journal of Cosmetic Dermatology ·Luiz Eduardo Toledo Avelar,(unknown),David S. Y. Ong,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	11
3	Ancestral SARS‐CoV‐2 and Omicron BA.5‐specific neutralizing antibody and T‐cell responses after Omicron bivalent booster vaccination in previously infected and infection‐naive individuals 2023 ·Journal of Medical Virology ·(unknown),(unknown),(unknown),(unknown),Johannes G.M. Koeleman,David S. Y. Ong	3
4	Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome 2021 ·American Journal of Respiratory and Critical Care Medicine ·Nanon F. L. Heijnen,Laura A. Hagens,Marry R. Smit,Olaf L. Cremer,David S. Y. Ong,Tom van der Poll,Lonneke A. van Vught,Brendon P. Scicluna,Ronny M. Schnabel,Iwan C.C. van der Horst,Marcus J. Schultz,Dennis C. J. J. Bergmans,Lieuwe D. J. Bos	50
5	How to interpret and use COVID-19 serology and immunology tests 2021 ·Clinical Microbiology and Infection ·David S. Y. Ong,Paraskevi C. Fragkou,Valentijn A. Schweitzer,Roy F. Chemaly,Charalampos D. Moschopoulos,Chrysanthi Skevaki	91
6	Comparison of the GeneFinderTM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection? 2020 ·Journal of Clinical Virology ·David S. Y. Ong,Eric C. J. Claas,(unknown),Norbert Vaessen	18
7	World Antibiotic Awareness Week and European Antibiotic Awareness Day, November 2018: An analysis of the impact of Twitter activity 2020 ·International Journal of Antimicrobial Agents ·Graham Mackenzie,David S. Y. Ong,Diane Ashiru‐Oredope	5
8	Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey 2019 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),Alberto Enrico Maraolo,David S. Y. Ong,(unknown),Philip Howard,Diamantis P. Kofteridis,Jeroen Schouten,Nico T. Mutters,C. Pulcini	15
9	Understanding Heterogeneity in Biologic Phenotypes of Acute Respiratory Distress Syndrome by Leukocyte Expression Profiles 2019 ·American Journal of Respiratory and Critical Care Medicine ·Lieuwe D. J. Bos,Brendon P. Scicluna,David S. Y. Ong,Olaf L. Cremer,Tom van der Poll,Marcus J. Schultz	85
10	How scientists and physicians use Twitter during a medical congress 2019 ·Clinical Microbiology and Infection ·Müge Çevik,David S. Y. Ong,Graham Mackenzie	17
11	Moderate positive predictive value of a multiplex real-time PCR on whole blood for pathogen detection in critically ill patients with sepsis 2019 ·European Journal of Clinical Microbiology & Infectious Diseases ·Kirsten van de Groep,Martine P. Bos,Meri R.J. Varkila,Paul H. M. Savelkoul,David S. Y. Ong,Lennie Derde,Nicole P. Juffermans,Tom van der Poll,Marc J. M. Bonten,Olaf L. Cremer	7
12	Fungi-Induced Upper and Lower Respiratory Tract Allergic Diseases: One Entity 2018 ·Frontiers in Microbiology ·Aleksandra Barać,David S. Y. Ong,Ljiljana Jovančević,Aleksandar Perić,Pavol Šurda,Vesna Tomić-Spirić,Salvatore Rubino	22
13	Macrolide therapy is associated with reduced mortality in acute respiratory distress syndrome (ARDS) patients 2018 ·Annals of Translational Medicine ·Fabienne D. Simonis,(unknown),Olaf L. Cremer,David S. Y. Ong,Tom van der Poll,Lieuwe D. J. Bos,Marcus J. Schultz	23
14	Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study 2016 ·American Journal of Respiratory and Critical Care Medicine ·Peter M. C. Klein Klouwenberg,Jos F. Frencken,Sanne Kuipers,David S. Y. Ong,Linda M. Peelen,Lonneke A. van Vught,Marcus J. Schultz,Tom van der Poll,Marc J. M. Bonten,Olaf L. Cremer	164
15	A Molecular Biomarker to Diagnose Community-acquired Pneumonia on Intensive Care Unit Admission 2015 ·American Journal of Respiratory and Critical Care Medicine ·Brendon P. Scicluna,Peter M. C. Klein Klouwenberg,Lonneke A. van Vught,Maryse A. Wiewel,David S. Y. Ong,Aeilko H. Zwinderman,Marek Franitza,Mohammad R. Toliat,Peter Nürnberg,Arie J. Hoogendijk,Janneke Horn,Olaf L. Cremer,Marcus J. Schultz,Marc J. M. Bonten,Tom van der Poll	151
16	Human bocavirus in stool: A true pathogen or an innocent bystander? 2015 ·Journal of Clinical Virology ·David S. Y. Ong,Rob Schuurman,E. Heikens	32
17	Antibiotic-Induced Within-Host Resistance Development of Gram-Negative Bacteria in Patients Receiving Selective Decontamination or Standard Care 2015 ·Critical Care Medicine ·(unknown),David S. Y. Ong,Evelien Oostdijk,Marcus J. Schultz,Evert de Jonge,Ilse M. Purmer,Dennis C. J. J. Bergmans,J. W. Fijen,Jozef Kesecioğlu,Marc J. M. Bonten	11
18	Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome 2015 ·Intensive Care Medicine ·David S. Y. Ong,Cristian Spitoni,Peter M. C. Klein Klouwenberg,Frans M. Verduyn Lunel,Jos F. Frencken,Marcus J. Schultz,Tom van der Poll,Jozef Kesecioğlu,Marc J. M. Bonten,Olaf L. Cremer	51
19	Electronic Implementation of a Novel Surveillance Paradigm for Ventilator-associated Events. Feasibility and Validation 2014 ·American Journal of Respiratory and Critical Care Medicine ·Peter M. C. Klein Klouwenberg,Maaike S. M. van Mourik,David S. Y. Ong,Janneke Horn,Marcus J. Schultz,Olaf L. Cremer,Marc J. M. Bonten	103
20	Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria 2012 ·Intensive Care Medicine ·Peter M. C. Klein Klouwenberg,David S. Y. Ong,Marc J. M. Bonten,Olaf L. Cremer	80

About David S. Y. Ong

David S. Y. Ong is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 87 papers that have together received 3.0k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (18 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and COVID-19 Clinical Research Studies (13 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (879 citations), Applied Microbiology and Biotechnology (180 citations) and Epidemiology (1.4k citations). David S. Y. Ong has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Olaf L. Cremer, Peter M. C. Klein Klouwenberg, Marc J. M. Bonten, Marcus J. Schultz, Tom van der Poll, Lonneke A. van Vught, Janneke Horn, Jos F. Frencken, Lieuwe D. J. Bos and Brendon P. Scicluna. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact